Bloodstream Infections in Kids Significantly Reduced With Quality Improvement Initiatives
Bloodstream infections associated with catheters can be significantly reduced through quality improvement efforts, possibly leading to better health outcomes and lives saved, decreased stays at the hospital and related costs, according to a new study.
The Cincinnati Childrens
"We were able to reduce the incidence of bloodstream infections after implementing a central line insertion and maintenance bundle, said Derek S. Wheeler, MD, a critical care physician at Cincinnati Childrens and the studys lead author. "This bundle emphasizes full sterile barrier precautions and chlorhexidine skin preparation during insertion, as well as daily discussion of catheter necessity and meticulous site and tubing care. Wheeler is also an assistant professor of clinical pediatrics at the University of Cincinnati College of Medicine.
The study will be presented at 7 p.m. ET Monday, May 3 at the annual Pediatric Academic Societies (PAS) meeting in
The study is one of two presented by Wheeler and colleagues this year at PAS that deal with catheter-associated bloodstream infections. The second study shows that a hospital-wide quality improvement collaborative resulted in a significant reduction in the incidence rate, from a baseline of 3.0 per 1,000 line days to less than 1.0 per 1,000 line days.
The collaborative approach included hospital-wide implementation of the same central line insertion and maintenance bundle on three critical care units, one oncology unit, one bone marrow transplant unit, and general medical/surgical units.
Catheter-associated bloodstream infections (CA-BSI) comprise the vast majority of hospital-acquired BSI in pediatric patients and are associated with increased length of stay (LOS), hospital costs and mortality.
Wheeler conducted the study in collaboration with researchers from Nationwide Childrens Hospital in
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.